Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Granisetron Dose Comparison for PONV in Strabismus Surgery
NCT04918862Phase 3Completed
- Sponsor
- Cairo University
- Start
- Jan 2021
- Primary completion
- May 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of granisetron in postoperative nausea and vomiting (PONV), sponsored by Cairo University. Started Jan 2021; status: completed.
02
Drugs
granisetron
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT04918862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04918862.